Tetratherix
Short position
Tetratherix (ASX:TTX) has 0.02% of its shares on issue reported as short positions as of 5 Oct 2026, or about 6,058 shares. Over the past 30 days that figure has been broadly flat, and over 7 days it has been broadly flat. TTX is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Tetratherix (TTX) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $918.2Kvs n/a (FY25)
- Yahoo Finance, as at 29 Sep 2026
- NPAT
- −$9.3Mvs −$9.4M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- −$0.18T (source: Derived: trailing 12 months at year end)vs −$0.36 (FY25)
- Derived: trailing 12 months at year end, as at 29 Sep 2026
- Rev YoY
- n/aFY
- EPS YoY
- n/aTTM
- Derived: trailing 12 months at year end
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 9 Oct 2026
- Gross margin
- 100.0%
- Operating margin
- −1,361.1%
- Net margin
- −1,015.1%
- FCF margin
- −863.8%
- ROE
- −31.1%
- ROA
- −21.9%
- FCF conversion
- n/a
- Net cash (excl. leases)
- $32.5M
- Net debt / EBITDA
- n/a
- Current ratio
- 4.5×
- Interest cover
- −126.8×
- Cash dividends paid / net profit
- n/a
- Market cap
- $336.2M
- P/E
- n/a
- P/B
- 10.3×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $918.2K | n/a | n/a | n/a |
| Gross profit | $918.2K | n/a | n/a | n/a |
| Operating income | −$12.5M | −$6.9M | −$5.3M | −$4.4M |
| EBITDA | −$8.3M | −$9.3M | −$4.3M | −$3.8M |
| EBIT | −$9.2M | −$9.4M | −$4.4M | −$3.8M |
| Interest expense | $98.6K | $68.2K | $120.0K | $136.0K |
| Pretax income | −$9.3M | −$9.4M | −$4.5M | −$4.0M |
| Tax | $0 | $0 | $0 | $0 |
| NPAT | −$9.3M | −$9.4M | −$4.5M | −$4.0M |
| Net interest income | $232.4K | $8.4K | −$120.0K | −$136.0K |
| EPS basic | −$0.18T (source: Derived: trailing 12 months at year end) | −$0.36 | −$0.090 | −$0.079 |
| EPS diluted | −$0.18T (source: Derived: trailing 12 months at year end) | −$0.36 | −$0.090 | −$0.079 |
| Shares | 53.0M | 50.3M | 50.3M | 50.3M |
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- Appendix 4E and Annual Report 2026Annual Results20 Aug 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report22 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report23 Apr 2026via asx_announcements
- Half Yearly Report and AccountsHalf Year Results24 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report28 Jan 2026via asx_announcements
- Q1FY26 Quarterly Activities Report/Appendix 4CQuarterly Report27 Oct 2025via asx_announcements
- 2025 Financial Results Investor PresentationFinancial Report28 Aug 2025via asx_announcements
- 2025 Financial Results AnnouncementFinancial Report28 Aug 2025via asx_announcements
- Appendix 4E and 2025 Annual ReportAnnual Results28 Aug 2025via asx_announcements
- 2025 Financial Results Investor WebinarFinancial Report28 Aug 2025via asx_announcements
Showing 10 of 13 reports